SCHEMBL29307145

SCHEMBL29307145

CCCOc1cc(F)cc(CCCCCC(=O)CC)c1

nearest known ligand 0.47

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 19/20 0.47
▸ CNR2 P34972 19/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27018353 0.89 CNR1 (0.47) CNR1CNR2
SCHEMBL23845075 0.82 CNR2 (0.47) CNR1CNR2
SCHEMBL18591909 0.81 LMNA (0.61) —
SCHEMBL18591900 0.78 LMNA (0.44) CNR1CNR2
SCHEMBL14445682 0.77 FAAH (0.43) —
SCHEMBL20443648 0.76 KDM4E (0.39) CNR1CNR2
SCHEMBL25123387 0.75 CNR2 (0.45) CNR1CNR2
SCHEMBL23842325 0.75 MTNR1A (0.36) CNR1CNR2
SCHEMBL25123024 0.74 CNR2 (0.35) CNR1CNR2
SCHEMBL20234613 0.73 KDM4E (0.40) CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024148060-A1 MK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2024-07-11 — — WO disclosed
Send feedback